Paper Details

  1. Home
  2. Paper Details

Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations.

Author: DissanayakeSanjeeva, GrotheBirgit, KaiserKirsten, MansurAdel H, McIverTammy, PapiAlberto, PertsevaTetyana

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

The study assessed the occurrence of oral corticosteroid-requiring exacerbations (OCS exacerbations) with long-term fluticasone/formoterol therapy compared to other ICS/LABA combinations.
Paper Details　
Original Abstract of the Article :
A primary goal of asthma management is the reduction of exacerbation risk. We assessed the occurrence of oral corticosteroid-requiring exacerbations (OCS exacerbations) with long-term fluticasone/formoterol therapy, and compared it with the occurrence of similar events reported with other inhaled co...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965704/

データ提供：米国国立医学図書館（NLM）

Fluticasone Propionate/Formoterol: A Powerful Weapon Against Asthma Exacerbations

Asthma is a chronic respiratory condition characterized by inflammation and airway narrowing, leading to recurring episodes of wheezing, coughing, and shortness of breath. This study investigated the long-term effectiveness of fluticasone propionate/formoterol fumarate combination therapy in reducing the risk of asthma exacerbations. The researchers compared the incidence of oral corticosteroid-requiring exacerbations (OCS exacerbations) in patients using fluticasone/formoterol with that of other inhaled corticosteroid/long-acting β2-agonist (ICS/LABA) combinations.

Fluticasone/Formoterol: A Promising Solution for Asthma Control

The study found that long-term fluticasone/formoterol therapy was associated with a low incidence of OCS exacerbations compared to other ICS/LABA combinations. This suggests that fluticasone/formoterol could be a valuable tool for managing asthma and reducing the frequency of severe exacerbations.

A New Era in Asthma Management: Navigating the Desert of Respiratory Disease

This study provides a promising new approach to managing asthma, highlighting the potential of fluticasone/formoterol as a powerful weapon against exacerbations. It underscores the importance of continued research and development in the field of respiratory medicine, as new and innovative treatments continue to emerge to improve the lives of those with asthma.

Dr.Camel's Conclusion

The desert of respiratory disease can be a challenging and uncomfortable place, where asthma exacerbations can disrupt daily life. This study offers a glimmer of hope, revealing the effectiveness of fluticasone/formoterol in reducing the risk of severe exacerbations. It's a reminder that the quest for better asthma management continues, with new and innovative treatments emerging to improve the quality of life for individuals with asthma.

Date :
  1. Date Completed 2017-06-06
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

27104231

DOI: Digital Object Identifier

PMC4965704

Related Literature

Article Analysis
・Effects of beclomethasone oral inhalation
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.